Introduction
============

Diabetic nephropathy (DN), as a common complication of diabetes mellitus, is the leading cause of end-stage renal disease and chronic renal failure ([@b1-ijmm-37-05-1290]). Although glomerular injury is thought to be the initiating factor of kidney damage in DN, previous research has indicated that tubular injury is also a key cause of chronic kidney injury ([@b2-ijmm-37-05-1290]), which correlates with the progression of DN ([@b3-ijmm-37-05-1290]). Tubular epithelial cell (TEC) apoptosis is considered a critical detrimental event which leads to kidney injury in cases of DN, and is closely associated with tubular atrophy and interstitial fibrosis ([@b4-ijmm-37-05-1290]). However, the mechanisms of tubular apoptosis during the progression of DN remain poorly understood.

Electron transfer flavoprotein β (ETFβ) is a subunit of ETF that is comprised of α and β subunits containing a flavin adenine dinucleotide (FAD) cofactor in the mitochondrial matrix. In the mitochondria, the oxidation of fatty acids is coupled with the mitochondrial transport chain through an electron transfer pathway, comprised of ETF-ubiquinone oxidoreductase (ETF-QO) and ubiquinone. Therefore, ETF acts as an electron acceptor of energy production from amino acid and fatty acids ([@b5-ijmm-37-05-1290]), which accepts electrons from flavoprotein dehydrogenases ([@b6-ijmm-37-05-1290]) and transfers them to ETF-QO in the inner mitochondrial membrane ([@b7-ijmm-37-05-1290]--[@b9-ijmm-37-05-1290]). Deficiency in human ETF results in a metabolic disease known as multiple acyl-CoA dehydrogenation deficiency (MADD) or glutaric acidemia type 2, and can even cause death in the neonatal period ([@b10-ijmm-37-05-1290]).

In the present study, in order to examine the role of ETFβ in DN, a spontaneous type 2 diabetic model using Otsuka Long-Evans Tokushima fatty (OLETF) rats was used in the present study. This rat model is characterized by obesity, insulin resistance, hyperglycemia, dyslipidemia and renal complications ([@b11-ijmm-37-05-1290]). More importantly, the renal abnormalities noted in OLETF rats resemble those of type 2 diabetic patients ([@b11-ijmm-37-05-1290]). Long-Evans Tokushima Otsuka (LETO) rats are the control counterpart animal model; these rats were developed from the same colony but do not develop diabetes. We previously observed a mutation of the ETFβ gene in the renal cortex of diabetic OLETF rats, which occured in conservative regions. The ETFβ gene mutation of H88L in OLETF rats suggested that ETFβ possibly plays a role in DN (unpublished data). Thus, in the present study, we examined the expression of ETFβ in DN patients and rats, and explored the mechanism of action in cell lines.

Materials and methods
=====================

Human kidney biopsy samples
---------------------------

Human kidney tissues were collected from patients in the Chinese Medicine Hospital of Shaanxi (Xi\'an, China). The medical information of patients was obtained by review of medical records and the tissues for clinical diagnosis were obtained from archived kidney biopsy specimens or discarded nephrectomy samples. The kidney tissues were from patients diagnosed with DN or kidney carcinoma without diabetes as the control. All patients with DN were diagnosed based on the presence of diabetes, massive proteinuria, and other histological changes typical of DN. Patients were aged between 48 and 65 years, the female:male ratio was 1:1, and proteinuria ranged from 2.3 to 4.3 g/24 h. Normal tissues around the tumor from kidney carcinoma patients were employed as the normal control; these patients were aged 51--65 years, the female:male ratio was 1:2, and proteinuria \<0.2 g/24 h. The patients were matched in terms of age and gender information. Kidney tissues from the patients were fixed in 10% phosphate-buffered formalin solution, embedded in paraffin, and then sectioned to 3-*µ*m thickness and stained with periodic acid-Schiff (PAS), TUNEL or used for immunohistochemical analyses. The study was approved by the Research Ethics Board of the Chinese Medicine Hospital of Shaanxi, and all patients provided informed consent.

Animals
-------

Male OLETF rats and corresponding controls, 4-week-old LETO rats, were kindly provided by the Tokushima Research Institute (Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan). During the experiments, rats were housed at 22±3°C in an atmosphere with 50±10% humidity and a 12-h light/dark cycle. Animals had free access to standard rat chow and tap water. Seven rats from the LETO control group and seven rats from the OLETF group were sacrificed using chloral hydrate at 36 weeks of age. The remaining seven rats of each group were sacrificed at 56 weeks of age. After sacrifice, blood samples were collected from the abdominal aorta, and kidneys were removed and separated for histopathological examination and biological analysis. Paraffin sections from rats were made as described above. The severity of DN was assessed by measuring urinary protein levels and PAS staining of kidney tissues with subsequent histopathological analysis. Animal experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animal of the National Institutes of Health. Procedures were approved by the Ethics Committee of Animal Experiments of the China-Japan Friendship Hospital (Beijing, China) (no. 08013).

Measuring body weight, blood glucose, blood lipids and urinary protein levels
-----------------------------------------------------------------------------

The body weight of rats was measured at 4-week intervals. Blood was sampled from the tail vein also at 4-week intervals, and blood glucose was measured using a OneTouch Ultra II Blood Glucose monitoring system (LifeScan, Inc., Milpitas, CA, USA). Total cholesterol (CHO) and triglyceride (TG) concentrations were measured using an AutoAnalyzer (Abbott Diagnostics, Abbott Park, IL, USA). Rats were housed in individual metabolic cages (Fengshi Laboratory Animal Equipment Co., Ltd., Suzhou, Jiangsu, China) for 24 h urine collection at 4-week intervals. Urinary protein was assessed using the Bradford method.

Kidney histological and immunohistochemical analyses
----------------------------------------------------

In the present study, PAS staining was performed on paraffin-embedded tissues from patients and rats using standard protocols. The degree of glomerulosclerosis, which was defined as a thickening of the basement membrane and mesangial expansion, was evaluated in 40 counted glomeruli using a microscope at ×400 magnification (BX51; Olympus, Tokyo, Japan), as previously described ([@b12-ijmm-37-05-1290]). The observer was blinded to all tissue samples. Tubulointerstitial injury was assessed in PAS-stained paraffin sections from rats at ×200 magnification using a similar scoring system (grades 1--6) as has been previously described ([@b12-ijmm-37-05-1290]). Briefly, 10 random cortical fields under ×200 magnification were outlined and positive staining patterns were subsequently identified. The percentage of positive area in the examined field was then measured, as previously described ([@b13-ijmm-37-05-1290]). Data are expressed as the means ± SE. All counting was performed on blinded slides.

Immunohistochemical analysis was performed as described in our previous study ([@b12-ijmm-37-05-1290]). Briefly, rat kidneys from each group were fixed in 10% formalin, embedded in paraffin, and cut into 3-*µ*m thick sections followed by rehydration. Antigen retrieval was undertaken in 10 mM citrate buffer (pH 6.0) at 90--95°C for 25 min. Kidney sections were incubated with polyclonal goat ETFβ antibody (1:200; sc-242638) (Santa Cruz Biotechnology, Inc., Dallas, TX, USA), overnight at 4°C. Following washing, slides were incubated with anti-rabbit secondary antibody in the same buffer. Immunohistochemical staining was performed using the GT Vision III Detection System/Mo Rb (Gene Tech Biotechnology Co., Ltd., Shanghai, China) and captured using a light microscope (Olympus) and quantified using Image Pro-Plus 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA).

Cell culture and RNA interference
---------------------------------

The normal rat kidney epithelial cell line (NRK-52E) was purchased from the Institute of Biochemistry and Cell Biology (Shanghai, China) and cultured in Dulbecco\'s modified Eagle\'s medium (DMEM; HyClone, Logan, UT, USA) supplemented with 25 mM D-glucose, 5% fetal bovine serum (FBS; Gibco Life Technologies, Carlsbad, CA, USA) in an incubator with 5% CO~2~ at 37°C. Cells were cultured until they reached 70% confluence, and this was followed by transfection with siRNA for 48 h.

NRK-52E cells were transfected with siRNA (20 *µ*m) targeting ETFβ or scrambled siRNA as negative control using Lipofectamine 3000 reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) according to the manufacturer\'s instructions. The siRNA sequences were as follows: sense, 5′-GGUGACUGCUGACUUAAGATT-3′ and antisense, 5′-UCUUAAGUCAGCAGUCACCTT-3′ (purchased from GenePharma, Shanghai, China). The scrambled siRNA sequences were as follows: sense, 5′-UUCUCCGAACGUGUCACGUTT-3′ and antisense, 5′-ACGUGACACGUUCGGAGAATT-3′. After transfection for 48 h, cells were harvested for total protein extraction or TUNEL detection. Untreated cells with no transfection were used as the nomal group.

TUNEL assay
-----------

For *in vivo* detection of apoptosis, apoptotic cells in the human and rat kidneys were examined by TUNEL assay according to the manufacturer\'s instructions (Roche Diagnostics GmbH, Mannheim, Germany). After formalin-fixed sections were dewaxed, the slides were heated with a microwave for 1 min in 0.1 M citrate buffer (pH 6.0), and rapidly cooled by adding doubled-distilled water and then transferred to PBS. The slides were blocked with buffer comprising 0.1 M Tris-Hcl, 3% BSA and 20% bovine serum (pH 7.5) for 30 min at room temperature. DNA fragments were then labeled by terminal transferase dUTP for 30 min at 37°C. In order to quantify apoptosis, the positively stained cells were calculated in 10 randomly selected fields in each slide as previously described ([@b14-ijmm-37-05-1290]).

For *in vitro* detection of apoptosis, NRK-52E cells were seeded in 96-well plates and transfected with ETFβ siRNA for 48 h as mentioned above. The cells were then rinsed twice, fixed in 4% paraformaldehyde for 20 min, and subsequently permeabilized with 0.1% Triton X-100 in PBS/BSA solution. TUNEL assay was performed according to the manufacturer\'s instructions and quantified as above.

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
----------------------------------------------------------------------

Total RNA was extracted from rat kidney cortices with TRIzol reagent (Invitrogen Life Technologies). cDNA was synthesized using a RevertAid First Strand cDNA Synthesis kit (Thermo Fisher Scientific, Waltham, MA, USA), and RT-qPCR was performed using UltraSYBR Mixture (CWBio, Inc., Beijing, China). Amplification was performed as follows: initial denaturation at 95°C for 2 min, followed by 40 cycles of denaturation at 95°C for 30 sec, annealing at 60°C for 30 sec and final extension at 72°C for 2 min, using an ABI 7500 thermocycler (Applied Biosystems, Foster, CA, USA). The primers used to detect ETFβ were: forward, 5′-GTACATTCGCCTCTCAGGTG-3′ and reverse, 5′-TACTCCTGCTAAGCGCTGAG-3′. The β-actin primers were forward, 5′-GACATCCGTAAAGACCTCTATGCC-3′ and reverse, 5′-ATAGAGCCACCAATCCACACAGAG-3′. Results were normalized to β-actin expression using the ΔΔC(t) method.

Western blot analysis
---------------------

In the present study, proteins for western blot analysis were extracted from the rat kidney tissues or NRK-52E cells by lysing with radioimmunoprecipitation assay (RIPA) buffer, as previously described ([@b12-ijmm-37-05-1290]). Mitochondrial proteins from rat kidneys were extracted and separated from cytosolic proteins as previously described ([@b15-ijmm-37-05-1290]). Briefly, the tissues were homogenized in 0.25 M sucrose and 10 mM Hepes, pH 7.0, in a glass homogenizer equipped with a motor-driven Teflon Pestle (1,000 rpm, five up-and-down). Mitochondria were prepared by centrifugation for 70 min at 70,000 × g twice. Mitochondria were first collected at the interface 0.25 M/1.6 M sucrose and then recovered under 1.45 M sucrose. As final purification steps, mitochondria pellets were submitted to successive washes at 23,000 × g, for 10 min and stored in liquid nitrogen. Protein concentration was tested by Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Protein extracts (30--40 *µ*g) were loaded on 12% SDS-PAGE and analyzed by western blot analysis. After blocking with 5% skim milk, membranes were then incubated with the following primary antibodies: ETFβ goat antibody at a 1:1,000 dilution (sc-242638), BAX mouse antibody at a dilution of 1:1,000 (sc-7480) and Bcl-2 mouse antibody at a dilution of 1:1,000 (sc-7382) (all purchased from Santa Cruz Biotechnology, Inc.) and cleaved caspase-3 rabbit antibody at a dilution of 1:500 (SAB 4503294) (Sigma-Aldrich, St. Louis, MO, USA). β-actin mouse antibody was used as the loading control for total protein at a dilution of 1:3,000 (KM 9001) (Tianjin Sungene Biotech Co., Ltd., Tianjin, China), and VDAC rabbit antibody (\#4866) (Cell Signaling Technology, Danvers, MA, USA) was used as the loading control for mitochondrial protein at a dilution of 1:1,000, overnight. Bands were detected using an ECL Western Blot Detection kit (Amersham Pharmacia Biotech, San Francisco, CA, USA) and subsequently quantified by densitometry using Quantity One software.

Statistical analyses
--------------------

All values are expressed as the means ± SEM. Results were analyzed using ANOVA or two-tailed Student\'s t-test. A P-value \<0.05 was considered to indicate a statistically significant difference.

Results
=======

Decreased expression of ETFβ in kidneys of patients with DN is accompanied by excessive numbers of apoptotic cells
------------------------------------------------------------------------------------------------------------------

Peri-carcinoma tissues from patients were used as a control, and kidney tissues from patients with DN were enrolled in the study; ten patients with DN and three patients with kidney carcinoma were enrolled in the study. Biopsies confirmed the presence of the disease, and PAS staining provided evidence for these pathological features ([Fig. 1A](#f1-ijmm-37-05-1290){ref-type="fig"}). We examined expression patterns of ETFβ protein in the kidney cortices of non-diabetic and diabetic humans. Compared with the normal tissue around the tumors, the expression of ETFβ was greatly reduced in kidney biopsy samples from patients with DN ([Fig. 1B](#f1-ijmm-37-05-1290){ref-type="fig"}). In addition, we noted that the distribution of ETFβ was primarily in the TECs, but rarely in the glomeruli. Excessive apoptotic nuclei were observed in the kidney tissues of DN patients using a TUNEL assay ([Fig. 1C](#f1-ijmm-37-05-1290){ref-type="fig"}). These findings are suggestive of a possible association between decreased tubular ETFβ expression and TEC apoptosis in cases of human DN.

Progression of DN in OLETF rats
-------------------------------

In the present study, the body weight of OLETF rats was significantly greater than that of LETO rats from 12 to 48 weeks ([Fig. 2A](#f2-ijmm-37-05-1290){ref-type="fig"}). However, as diabetes developed, no significant difference was observed between 53 and 56 weeks. The blood glucose levels of OLETF rats were significantly elevated at 48 weeks and peaked at 53 weeks ([Fig. 2B](#f2-ijmm-37-05-1290){ref-type="fig"}), which was associated with the development of proteinuria ([Fig. 2D](#f2-ijmm-37-05-1290){ref-type="fig"}), glomerulosclerosis index and tubulointerstitial injury index ([Fig. 3](#f3-ijmm-37-05-1290){ref-type="fig"}). Moreover, high levels of blood lipids, including serum CHO and TG concentration were marked at 56 weeks of age ([Fig. 2C](#f2-ijmm-37-05-1290){ref-type="fig"}). Serum TG level increased at an early stage, whereas serum CHO levels were elevated later. There was mild glomerular and tubular injury as early as 36 weeks of age, and this then progressed to severe glomerulosclerosis and tubular atrophy and tubulointerstitial fibrosis at 56 weeks ([Fig. 3](#f3-ijmm-37-05-1290){ref-type="fig"}).

In the kidney cortices of OLETF rats, elevated expression of BAX/Bcl-2 and cleaved caspase-3 occurred only at 56 weeks of age ([Fig. 4A and B](#f4-ijmm-37-05-1290){ref-type="fig"}), whereas there was no significant change in expression at 36 weeks of age (P\>0.05, data not shown). In agreement with the molecular changes involved in apoptosis, the occurrence of apoptosis in the diabetic kidneys also increased in 56-week-old OLETF rats, as evidenced by the results of the TUNEL assay ([Fig. 4C and D](#f4-ijmm-37-05-1290){ref-type="fig"}).

Decreased expression of ETFβ in diabetic kidney and the progression of DN in OLETF rats
---------------------------------------------------------------------------------------

By contrast, we noted that the expression of ETFβ was high in the kidneys of control LETO rats, but it was markedly decreased in the kidneys of diabetic OLETF rats ([Fig. 5](#f5-ijmm-37-05-1290){ref-type="fig"}). ETFβ mRNA and protein levels were both markedly downregulated only at 56 weeks of age ([Fig. 5A and B](#f5-ijmm-37-05-1290){ref-type="fig"}). ETFβ expression was also reduced in mitochondria, which confirmed the ETFβ decrease prior to loss of mitochondria, since we separated the mitochondrial fraction and tested ETFβ expression with VDAC as a mitochondria control ([Fig. 5C](#f5-ijmm-37-05-1290){ref-type="fig"}). Immunohistochemistry results indicated that ETFβ was widely expressed and located in normal tubular region, compared with glomerular region ([Fig. 5D and E](#f5-ijmm-37-05-1290){ref-type="fig"}).

In 56-week-old OLETF rats we noted increased levels of BAX/Bcl-2 ratio and cleaved caspase 3, and decreased ETFβ in kidneys, which was linked with TEC apoptosis, as demonstrated by the significant increase in TUNEL-positive cells ([Fig. 4](#f4-ijmm-37-05-1290){ref-type="fig"}).

Knockdown of ETFβ results in NRK-52E cell apoptosis
---------------------------------------------------

In order to better understand the functional role of ETFβ in TEC apoptosis, we knocked down ETFβ in NRK-52E cells. As shown in [Fig. 6A and B](#f6-ijmm-37-05-1290){ref-type="fig"}, knockdown of ETFβ reduced the protein expression levels of ETFβ significantly, which elevated expressions of BAX and cleaved caspase-3. There was also decreased expression of Bcl-2. Moreover, in ETFβ siRNA treated cells, inhibiton of ETFβ expression caused increased apoptosis of cells compared with normal cells or cells transfected with scrambled siRNA ([Fig. 6C](#f6-ijmm-37-05-1290){ref-type="fig"}).

Discussion
==========

Although tubular atrophy and tubulointerstitial fibrosis associated with tubular apoptosis are the most convincing evidence for the progression of DN ([@b16-ijmm-37-05-1290]), the mechanisms underlying this progression were poorly understood. In the present study, we noted excessive apoptosis, which was associated with progressive renal injury in diabetic patients and rats. To our surprise, we discovered that a significant decrease in ETFβ was associated with an increase in TEC apoptosis and progressive renal injury in the diabetic patients and rats, which suggests a negative link between ETFβ expression and TEC apoptosis. Importantly, downregulation of ETFβ by employing siRNA resulted in significant apoptosis of NRK-52E cells. Therefore, we suggest that decreased expression of ETFβ is closely related to apoptosis in TECs.

Tubular cell apoptosis occurs earlier than the onset of kidney fibrosis, and results in matrix accumulation in the tubulointerstitium ([@b17-ijmm-37-05-1290]). Previous research has shown that apoptosis is one of the pathological features of progressive kidney injury in patients with diabetes ([@b18-ijmm-37-05-1290]). Oxidative stress and mitochondrial dysfunction have been reported to contribute to tubular cell apoptosis ([@b19-ijmm-37-05-1290],[@b20-ijmm-37-05-1290]), but the mechanisms mediating excessive apoptosis during the course of DN have not been fully explored. Downregulation of ETFβ associated with type 2 diabetes was noted using a quantitative proteomic approach and mouse pancreatic islets ([@b21-ijmm-37-05-1290]). In the present study, we discovered that decreased ETFβ resulted in tubular cell apoptosis, which is a cause of DN.

In the present study, we found that decreased ETFβ expression was accompied by tubular cell apoptosis both in human samples and rat kidney samples. The elevated BAX/Bcl-2 ratio in diabetic OLETF rats activates subsequent apoptotic signaling and cleaves pro-caspase-3 to the active form ([@b22-ijmm-37-05-1290]). Cleaved caspase-3 expression is considered a hallmark of apoptosis ([@b23-ijmm-37-05-1290]), and our data demonstrated eleveated cleaved caspase-3 expression in the kidney cortices of 56-week-old diabetic rats, which was consistent with decreased expression of ETFβ and increased TUNEL-positive stainings.

The suppression of ETFβ in TECs may be a result of the diabetic conditions of high glucose and dyslipidemia; in fatty acid β-oxidation, amino acid oxidation, and choline metabolism, ETF is positioned at a key metabolic branch point, as it accepts electrons from at least nine dehydrogenases and transfers them to the membrane-bound respiratory chain ([@b24-ijmm-37-05-1290]). According to functional and structural research of ETFβ, the absence of the ETFβ subunit is a result of its role as a \'fixed\' electron carrier, but it should be flexible to adapt different structural dehydrogenases upstream ([@b8-ijmm-37-05-1290]). However, the mechanism by which ETFβ is regulated in cases of diabetes is still unclear and requires further investigation. Previous study has demonstrated that elevation of upstream dehydrogenase by peroxisome proliferator-activated receptor δ attenuated apoptosis induced by fatty acids in a β-cell line ([@b25-ijmm-37-05-1290]). Moreover, the expression of ETF is significantly downregulated in human vein endothelial cells when apoptosis is induced by digoxin ([@b26-ijmm-37-05-1290]).

The results of our present study demonstrated that decreased expression of ETFβ was associated with TEC apoptosis, suggesting that ETFβ plays a protective role in TEC apoptosis. In the tubular regions, the mitochondrial β-oxidation pathway is much better developed than in glomerular regions ([@b27-ijmm-37-05-1290]). Therefore, as the electron receptor for the first reaction of fatty acid β-oxidation, ETFβ deficiency in the tubular cells may cause decreased energy supply ([@b28-ijmm-37-05-1290]). Also, since the physiological upstream acceptors for the electrons are missing, decreased expression of ETFβ may result in generation of excessive ROS ([@b29-ijmm-37-05-1290]). Oxidative stress induced by ROS has been suggested to be a common mediator in apoptosis ([@b30-ijmm-37-05-1290],[@b31-ijmm-37-05-1290]) and particularly in DN, a state in which oxidative stress is increased by high glucose and dyslipidemia ([@b32-ijmm-37-05-1290]).

In conclusion, for the first time to the best of our knowledge, the present study provided evidence that ETFβ expression is decreased in kidneys of diabetics, and this is associated with TEC apoptosis and renal injury. Moreover, downregulation of ETFβ by siRNA induces apoptosis of renal tubular cells. In conclusion, decreased expression of ETFβ in DN is associated with TEC apoptosis during the progression of diabetes.
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Expression of electron transfer flavoprotein β (ETFβ) and apoptosis detection in kidney samples of patients with diabetic nephropathy (DN) and normal tissues from around the kidney tumor. (A) Periodic acid-Schiff (PAS) staining (original magnification, x400) in human kidney tissues. (B) Expression of ETFβ in human biopsy samples, detected by immunohistochemical analysis. (C) Apoptosis in cells from human kidney cortex biopsy specimens, as detected by TUNEL assay. These stainings are from ten patients with DN and three patients with kidney carcinoma, respectively.
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\(A\) Body weight, (B) blood glucose, (C) blood lipids and (D) 24 h urinary protein levels of Otsuka Long-Evans Tokushima fatty (OLETF) and Long-Evans Tokushima Otsuka (LETO) rats during progression to severe diabetic nephropathy (DN). Data are expressed as the means ± SEM of 7 rats from each group. ^\*^P\<0.01 compared with LETO rats at the corresponding intervals.
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Periodic acid-Schiff (PAS) staining (original magnification, ×400) of the renal glomerular and tubular regions of Otsuka Long-Evans Tokushima fatty (OLETF) and Long-Evans Tokushima Otsuka (LETO) rats at 36 and 56 weeks of age respectively. (A) PAS staining of renal glomerulus and (B) semi-quantitative analysis of glomerulosclerosis. (C) PAS staining of renal tubules and (D) semiquantitative analysis of tubulointerstitial injury. Data are expressed as the means ± SEM from 7 rats. ^\*^P\<0.01 compared with LETO rats.
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Apoptosis-related protein expression in 56-week-old rats and TUNEL staining using kidney samples from Otsuka Long-Evans Tokushima fatty (OLETF) and Long-Evans Tokushima Otsuka (LETO) rats at 36 and 56 weeks of age. (A) Representative western blots of BAX, Bcl-2, and cleaved caspase-3 in the kidney cortices of OLETF and LETO rats at 56 weeks of age. (B) Histogram shows semiquantitative analysis for each band. (C) Apoptotic cells in the kidney cortex, as shown by TUNEL positive staining (original magnification, ×400) in rats at the two time points. (D) Histogram shows semiquantitative analysis of tubular cell apoptosis. Data are expressed as the means ± SEM from 7 rats. ^\*^P\<0.01 compared with LETO rats.
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Expression of electron transfer flavoprotein β (ETFβ) in the kidneys during the progression of diabetic nephropathy (DN) in rats at 36 and 56 weeks of age respectively. (A) mRNA levels of ETFβ in the kidneys of Otsuka Long-Evans Tokushima fatty (OLETF) vs. Long-Evans Tokushima Otsuka (LETO) rats, as measured by RT-qPCR. (B) The expression of ETFβ in the kidney cortices of rats, as measured by western blot analysis. (C) ETFβ protein levels in the mitochondrial fraction from the kidney cortices of rats, as measured by western blot analysis. (D) Representative pictures of immunostaining (original magnification, ×400) of ETFβ and (E) semiquantitative analysis. Data are expressed as the means ± SEM from 7 rats. ^\*^P\<0.01 compared with LETO rats.
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Effect of electron transfer flavoprotein β (ETFβ) knockdown on apoptosis in normal rat kidney epithelial (NRK-52E) cells. (A) Effect of ETFβ knockdown on the expression of apoptosis-related proteins. (B) Histogram represents the semiquantitative analysis of bands. (C) Apoptotic ratio of NRK-52E cells (original magnification, ×400) as evidenced by TUNEL staining and histogram showing the semiquantitative analysis results. Data are expressed as the means ± SEM from three independent experiments. ^\*^P\<0.01 compared with scrambled siRNA group.
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